Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2261
-
2262
Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28).
Published 2025“…Expression of 7 proteins significantly correlated with stereotypy severity in CD1 mice. …”
-
2263
Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.
Published 2025Subjects: -
2264
-
2265
-
2266
-
2267
-
2268
Amplitude for A/L = 0.29.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2269
Amplitude for A/L = 0.338.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2270
Amplitude for A/L = 0.02.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2271
Amplitude for A/L = 0.03.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2272
AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves.
Published 2025Subjects: -
2273
-
2274
Comparison in baseline variables between efficacy group and non-efficacy group.
Published 2025Subjects: -
2275
-
2276
-
2277
Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx
Published 2025“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …”
-
2278
-
2279
Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress.
Published 2025“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”
-
2280
Association between workability and sociodemographic and occupational characteristics.
Published 2025Subjects: